Gene Query: PIKFYVE

Dataset Description Geneva Score
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 48.04
Selective suppression of endothelial cytokine production by progesterone receptor 48.04
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 30.98
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 23.7
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression (RNA-seq) 22.93
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression 22.93
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 22.79
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 22.54
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 21.6
Silencing SPIB in attached and floating state of H1703 lung cancer cells 21.08
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 20.46
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 20.45
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 20.42
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 20.21
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 19.4
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 18.96
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 18.14
RNA sequencing of mechanically strained NHEKs and control NHEKs 17.92
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 17.75
The cytokine environment influence on human skin-derived T cells 17.36
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 16.94
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 16.94
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 16.72
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival 16.46
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival [RNA-Seq] 16.46
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 16.33
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 16.12
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 16.05
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 15.95
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 15.95
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 15.79
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 15.63
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 15.44
Impact of dieldrin on transcription in Jurkat T cells 15.25
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 14.58
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 14.32
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 14.32
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 14.32
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 13.95
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 13.85
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 13.63
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 13.53
13.49
RIG-I and MDA5 fRIP during KSHV lytic reactivation 13.35
miRNAs affected by antagomiR-17 treatment 13.32
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 13.15
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 13.15
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 13.15
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 13.15
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 13.04
Genetic-to-epigenetic Therapy for Pancreatic Cancer 12.96
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 12.74
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 12.65
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 12.02
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 11.99
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 11.91
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 11.81
Effect of PRDM11 depletion in U2932 cells 11.6
Mutational landscape of splicing genes and functional consequences across 33 cancer types 11.49
MYCL and EP400 are required for Max and MCPyV mediated gene activation 11.37
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 11.36
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 11.34
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 11.22
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 10.72
Knockdown of ADNP in HCT116 colon cancer cells 10.71
Genome-wide transcriptome profiling of NEDD9-regulated genes using RNA-seq 10.7
NRDE2 negatively regulates nuclear exosome functions 10.65
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 10.5
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 10.48
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 10.48
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 10.39
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 10.39
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 10.33
hTERT promotes cell adhesion and migration independent of telomerase activity 10.31
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors 10.28
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 10.28
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 10.21
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 10.15
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 10.15
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 10.12
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 10.01
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 9.99
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 9.99
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 9.95
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 9.95
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 9.95
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 9.95
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 9.93
Gene expression data from IMR90 control, IMR90 shRRM2 and shRRM2/shp16 9.92
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 9.92
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 9.86
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 9.83
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 9.79
Effect of PBK knockdown on C4-2 cell transcriptome 9.78
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 9.73
Lysine benzoylation is a novel histone mark [RNA-seq] 9.43
Lysine benzoylation is a novel histone mark 9.43
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 9.41
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 9.41
Novel Targeting of Transcription and Metabolism in Glioblastoma 9.37
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 9.36
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 9.35
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 9.31
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 9.3
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 9.2
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 9.2
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 9.2
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 9.19
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 9.15
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 9.1
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 9.07
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 9.06
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 9.01
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 8.92
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 8.91
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 8.91
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 8.91
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 8.73
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 8.72
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 8.61
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 8.51
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 8.44
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 8.32
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 8.32
RNA-seq of human fibroblasts after irradiation 8.32
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_1A_PI3K_RNA-seq] 8.31
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 8.27
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 8.25
Genes significantly down or Up-regulated upon RNF219 knockdown 8.25
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 8.21
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 8.14
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 8.13
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 8.06
Transcriptomic analysis of LSD1 7.94
CD73 knockdown effect in pancreatic cancer cell lines 7.91
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 7.89
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 7.87
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 7.86
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 7.86
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 7.85
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 7.83
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 7.83
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 7.77
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 7.7
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 7.67
The effect of spontaneous acquisition of an extra chromosome 7 for engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 7.66
RNA-seq of resting and activated CD4+ T cells +-JQ1 7.66
Mechanistic Model-Guided Study of Embryonic Morphogenesis 7.65
MYC dependent mRNA translation shapes gene expression and cell biology 7.64
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 7.6
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 7.57
Transcriptomic profiling of human peripheral blood-derived mast cells 7.57
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 7.57
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 7.5
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 7.47
Regulation of poly(A) tail and translation during the somatic cell cycle 7.46
RNAseq Study in CC-671 Treated Cal-51 Cells 7.45
RNA-seq of RKO cells with cTAZ KO or putback 7.37
MYCi361 regulates MYC target genes 7.37
Landscape of H3K4me3 in human CD19 cells 7.37
Inhibition of TNBC metastasis by Gpx1 7.33
Transcript abundance in A-T-derived iPSC: Comparing isogenic cells to unrelated individual 7.32
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 7.32
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 7.28
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 7.26
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 7.23
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 7.22
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 7.2
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 7.2
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 7.19
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 7.18
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma [RNA-Seq] 7.18
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma 7.18
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 7.12
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 7.12
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 7.12
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 7.09
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 7.09
Searching for target genes of miR-508/509/506/514 in HCT116 cells 7.07
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 7.03
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 7.03
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 6.99
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 6.99
Post-transcriptional remodelling is temporally deregulated during motor neurogenesis in human ALS models 6.98
Changes in human endometrial gland transcriptome over the window of implantation 6.93
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 6.92
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 6.87
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 6.85
Human cell line and subcutaneous tumor 6.83
WRN knockout effects upon gene expression in SW48 and OVK18 6.81
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 6.78
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 6.76
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 6.69
Induced DNA demethylation, genome instability and transcription 6.68
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 6.68
Gene expression profiling of leukemia cells following asparagine depletion 6.65
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 6.64
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer 6.61
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 6.58
TT-Seq captures the human transient transcriptome 6.55
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 6.53
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 6.52
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 6.52
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 6.52
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 6.51
Global Mapping of Human RNA-RNA Interactions 6.44
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 6.37
RNA-seq analysis to identify the genes regulated by p53-SET interplay 6.32
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 6.3
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 6.3
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 6.3
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma 6.28
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 6.28
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 6.2
Statins modulate endothelial transcriptional profile by inhibiting EZH2 6.18
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 6.16
Landscape and variation of RNA secondary structure across the human transcriptome 6.13
Cajal bodies are linked to genome conformation 6.06
Cajal bodies are linked to genome conformation [RNA-Seq] 6.06
Expression data from miR340 overexpressing human A549 cells 6.06
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 6.03
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 6.03
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 6.01
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 6.01
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 6.01
The cohesin release factor WAPL restricts chromatin loop extension. 5.98
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 5.98
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 5.97
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 5.95
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 5.92
Genome-wide discovery of human splicing branchpoints 5.91
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 5.89
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 5.89
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 5.89
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 5.86
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 5.84
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 5.82
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 5.77
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 5.74
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 5.74
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 5.7
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 5.63
RNA-seq of shEZH2 cells 5.62
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 5.58
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 5.57
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 5.57
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 5.57
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 5.57
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 5.57
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 5.53
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 5.53
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 5.52
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 5.52
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 5.49
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 5.48
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 5.48
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 5.47
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 5.46
The contribution of Alu exons to the human proteome 5.45
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 5.43
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 5.43
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 5.42
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 5.41
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 5.41
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 5.37
Gene expression in GBM with Cav3.2 inhibition 5.37
Mapping interactions for the TNIP2 hub protein 5.35
Be1 and Be2 B cells are transcriptionally distinct 5.34
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 5.29
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 5.27
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 5.27
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 5.24
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 5.2
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 5.15
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 5.07
K562 polyA RNA-Seq 5.06
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 4.98
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 4.97
Human stem cell based models of neuronal migration provide insight into neurological disease pathogenesis and potential treatment 4.96
BASP1 modifies the Tamoxifen response 4.91
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 4.86
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 4.84
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 4.84
RNA Seq of HMVEC under hypoxia 4.83
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 4.83
Global transcriptome analysis of HAP1 cells 4.8
Targeting MTHFD2 in Acute Myeloid Leukemia 4.79
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 4.73
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 4.73
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 4.68
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 4.67
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 4.64
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 4.62
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 4.61
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 4.56
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 4.55
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 4.54
X-Ray induced DNA-Hydroxymethylation changes 4.52
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 4.47
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 4.44
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 4.43
Defective structural RNA processing in relapsing-remitting multiple sclerosis 4.42
RNA-seq analysis upon ARID1B overexpression 4.42
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 4.37
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 4.35
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 4.35
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 4.3
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 4.28
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 4.28
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 4.28
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 4.2
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 4.19
Transcriptome analysis of peripheral blood monocytes 4.17
Loss of endometrial plasticity in recurrent pregnancy loss (RNA-Seq) 4.16
Loss of endometrial plasticity in recurrent pregnancy loss 4.16
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 4.15
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 4.14
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 4.12
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 4.11
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 4.11
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 4.05
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq2] 4.03
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 4.02
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 3.97
naive T cell heterogeneity after neonatal thymectomy 3.97
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 3.95
A20 regulates canonical wnt-signaling through an interaction with RIPK4 3.89
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 3.86
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 3.85
Real-time observation of light-controlled transcription in living cells 3.78
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 3.77
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 3.77
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 3.67
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 3.35
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 3.35
Microprocessor mediates transcription termination in long noncoding microRNA genes 3.25
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 3.23
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 3.21
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 3.17
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 3.17
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 3.16
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 3.12
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 3.12
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 3.09
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 3.05
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 3.05
Improved post thaw function and genetic changes for mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions 3.03
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 2.97
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 2.97
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 2.95
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 2.94
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 2.94
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 2.88
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 2.82
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 2.81
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 2.81
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 2.75
Transcriptome analysis of BAP1 knockout and restoration 2.75
Deletions in the ATAD3 gene cluster cause cerebellar developmental defects with mitochondrial DNA abnormalities owing to local cholesterol insufficiency 2.73
4sU-seq of HFF exposed to salt and heat stress 2.72
Gene expression changes after LOC550643 silencing 2.7
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 2.63
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 2.63
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 2.6
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 2.54
MYOD Gene Expression Regulation during Myogenic Conversion of Fibroblasts 2.53
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 2.49
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 2.48
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 2.48
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 2.47
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 2.46
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 2.42
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 2.36
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 2.33
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 2.33
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 2.32
The circadian transcriptional landscape in primary human mammary epithelial cells 2.32
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 2.28
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 2.27
Transcription profile analysis of wild type and Irf9-/- human monocytic THP1 cells in response to type I interferons 2.26
Irf9 function in immunity in mouse 2.26
MYCi975 regulates MYC target genes 2.22
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 2.22
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 2.21
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 2.21
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity 2.21
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 2.13
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 2.09
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 2.03
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 2.02
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 2.0
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 1.96
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 1.96
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 1.94
Epigenetic and transcriptional analysis of mesoderm progenitor cells identifies HOPX as a novel regulator of hemogenic endothelium 1.94
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 1.91
mRNA-Seq profiling of human developing kidney 1.86
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 1.85
Aneuploidy triggers an immune response 1.84
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 1.83
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 1.83
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 1.82
Frailty in middle age is associated with race-specific changes to the transcriptome. 1.82
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 1.81
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 1.79
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 1.78
TOP2B disturbed the quality of human oocytes with advanced maternal age 1.6
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 1.49
Measure transcript integrity using RNA-seq data 1.44
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 1.43
Gene expression changes due to PARP knockdown in human cells 1.42
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 1.42
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 1.41
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 1.41
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 1.4
An evolutionary recent IFN-IL-6-CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. 1.39
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 1.37
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 1.36
WNT signaling memory is required for ACTIVIN to function as a morphogen 1.31
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 1.31
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 1.29
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 1.29
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 1.29
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 1.28
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.28
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 1.26
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 1.26
EWS-Fli and LNC regulated genes in comparison to GFP samples 1.23
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 1.22
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 1.18
Effects of transcription on genome - nuclear lamina interactions 1.18
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 1.18
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 1.13
Transcriptome analysis of CNS leukemia 1.13
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 1.1
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 1.1
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 1.06
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 1.06
DIGIT regulates endoderm differentiation of human embryonic stem cells 1.01
Human ovarian granulosa cell transcriptome 0.99
HBEC-shp53-PCHD7 0.99
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.98
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.98
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 0.95
A code of mono-phosphorylation modulates the function of RB. 0.95
RNA-seq analysis of control and Myc-induced U2OS cells 0.86
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.85
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 0.84
Identification of a LIF-responsive replication-competent human β cell 0.81
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 0.78
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 0.78
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.76
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.76
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 0.73
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.72
Pomalidomide inhibits PD-L1 induction to promote anti-tumor immunity 0.71
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.71
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 0.7
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 0.69
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 0.68
EGR1-controlled transcriptome of T HESCs 0.67
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 0.67
Transcriptome of human ILC2s; primary vs IL-1b-primed 0.66
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 0.63
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 0.61
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 0.59
In situ CAPTURE of chromatin interactions by biotinylated dCas9 0.59
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 0.59
The control of rRNA synthesis during the directed differentiation of human embryonic stem cells precedes heterochromatin formation. 0.59
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 0.57
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 0.57
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 0.54
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 0.47
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 0.47
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 0.45
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 0.43
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 0.43
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.37
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 0.34
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.34
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.29
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 0.28
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.26
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.25
Human T-cell lymphoblastic lymphoma samples and control thymuses 0.24
RNA-Seq in human T-cell lymphoblastic lymphoma samples and control thymuses 0.24
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.23
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 0.2
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 0.16
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.15
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.13
Modulation of nonsense-mediated decay by rapamycin 0.12
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.09
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 0.08
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 0.06
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 0.06
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.03
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 0.03
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.01
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation